Predictions
Orpea Nom.
Start price
Target price
Perf. (%)
€2.17
08.02.23
08.02.23
-
08.02.24
08.02.24
-9.35%
03.04.23
03.04.23
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.77
21.03.23
21.03.23
-
21.03.24
21.03.24
-7.32%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
Novocure Ltd
Start price
Target price
Perf. (%)
€64.20
16.03.22
16.03.22
€68.00
16.03.23
16.03.23
-6.99%
17.03.23
17.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.63
19.11.22
19.11.22
€2.50
19.11.23
19.11.23
-46.91%
11.03.23
11.03.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Orpea Nom.
Start price
Target price
Perf. (%)
€2.58
20.02.23
20.02.23
-
20.02.24
20.02.24
-1.16%
05.03.23
05.03.23
Could be very worthwhile Investment >20% year
Nektar Therapeutics
Start price
Target price
Perf. (%)
€2.02
23.01.23
23.01.23
-
23.01.24
23.01.24
-28.00%
03.03.23
03.03.23
Risky Investment
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
01.03.23
01.03.23
€14.00
-
02.03.23
02.03.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Orpea Nom.
Start price
Target price
Perf. (%)
€5.54
01.02.23
01.02.23
-
01.02.24
01.02.24
-48.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.42
22.01.23
22.01.23
-
22.01.24
22.01.24
12.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.86
23.04.16
23.04.16
€18.58
22.10.24
22.10.24
40.44%
24.01.23
24.01.23
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.15
12.01.22
12.01.22
-
12.01.23
12.01.23
12.55%
13.01.23
13.01.23
Novocure Ltd
Start price
Target price
Perf. (%)
€68.89
02.01.23
02.01.23
€30.00
31.12.25
31.12.25
71.43%
05.01.23
05.01.23
Could be very worthwhile Investment >20% year
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€61.22
07.09.22
07.09.22
€100.00
31.12.25
31.12.25
73.41%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€8.47
13.12.21
13.12.21
-
13.12.22
13.12.22
-67.06%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.20
07.12.22
07.12.22
-
07.12.23
07.12.23
-16.53%
10.12.22
10.12.22
Risky Investment